Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use

US6566340B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Wendelin Frick · Bad Camberg, DE
• Reinhard Kirsch · Braunschweig, DE
• Heiner Glombik · Hofheim, DE
• Werner Kramer · Schwandorf, DE
• Hans-Ludwig Schafer · Hochheim, DE

Key dates

• Filing date: Apr 13, 2001
• Grant date: May 20, 2003
• Expiry date: May 5, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described.Also described are compounds of formula I in which the radicals have the abovementioned meanings, and their physiologically tolerated salts, physiologically functional derivates and processes for their preparation. The compounds are suitable as, for example, hypolipidemics.